Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study

MLA

Katarina Mitrova, et al. “Differences in the Placental Pharmacokinetics of Vedolizumab and Ustekinumab during Pregnancy in Women with Inflammatory Bowel Disease: A Prospective Multicentre Study.” Therapeutic Advances in Gastroenterology, vol. 14, Aug. 2021. EBSCOhost, https://doi.org/10.1177/17562848211032790.

APA

Katarina Mitrova, Barbora Pipek, Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, Pavel Drastich, Premysl Falt, Pavel Klvana, Vaclav Leksa, Ales Novotny, Pavel Svoboda, Jan Skorpik, Jan Ulbrych, Marek Veinfurt, Blanka Zborilova, Milan Lukas, & Dana Duricova. (2021). Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study. Therapeutic Advances in Gastroenterology, 14. https://doi.org/10.1177/17562848211032790

Chicago

Katarina Mitrova, Barbora Pipek, Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, et al. 2021. “Differences in the Placental Pharmacokinetics of Vedolizumab and Ustekinumab during Pregnancy in Women with Inflammatory Bowel Disease: A Prospective Multicentre Study.” Therapeutic Advances in Gastroenterology 14 (August). doi:10.1177/17562848211032790.